Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;15(3):228-235.
doi: 10.1002/wps.20345.

Abandoning personalization to get to precision in the pharmacotherapy of depression

Affiliations

Abandoning personalization to get to precision in the pharmacotherapy of depression

Roy H Perlis. World Psychiatry. 2016 Oct.

Abstract

Effectiveness studies and analyses of naturalistic cohorts demonstrate that many patients with major depressive disorder do not experience symptomatic remission with antidepressant treatments. In an effort to better match patients with effective treatments, numerous investigations of predictors or moderators of treatment response have been reported over the past five decades, including clinical features as well as biological measures. However, none of these have entered routine clinical practice; instead, clinicians typically personalize treatment on the basis of patient preferences as well as their own. Here, we review the reasons why it has been challenging to identify and deploy treatment-specific predictors of response, and suggest strategies that may be required to achieve true precision in the pharmacotherapy of depression. We emphasize the need for changes in how depression care is delivered, measured, and used to inform future practice.

Keywords: Antidepressants; biomarkers; major depression; personalized medicine; precision medicine; risk stratification; treatment matching.

PubMed Disclaimer

References

    1. Johnson CF, Dougall NJ, Williams B et al. Patient factors associated with SSRI dose for depression treatment in general practice: a primary care cross sectional study. BMC Family Pract 2014;15:210. - PMC - PubMed
    1. von Wolff A, Meister R, Harter M et al. Treatment patterns in inpatient depression care. Int J Methods Psychiatr Res 2016;25:55‐67. - PMC - PubMed
    1. Goldberg JF, Freeman MP, Balon R et al. The American Society of Clinical Psychopharmacology Survey of Psychopharmacologists' Practice Patterns for the Treatment of Mood Disorders. Depress Anxiety 2015;32:605‐13. - PubMed
    1. Herbild L, Bech M, Gyrd‐Hansen D. Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression. Value Health 2009;12:560‐7. - PubMed
    1. National Research Council of the National Academies. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington: National Academies Press, 2011. - PubMed